CCCC:NASDAQ, C4 Therapeutics, Inc.
CCCC stock overview
C4 Therapeutics, Inc. (CCCC:NASDAQ) closed at $2.48 on November 20, 2026,
up 1.64% on the day.
The stock trades 52.0% below its 52-week high of $5.17
and 46.7% above its 52-week low of $1.69.
Over the past year, it gained 1.6%.
C4 Therapeutics, Inc. is part of the Health Care sector.
Key figures
- Price
- $2.48
- Day change
- +1.64%
- Volume
- 3,628,833
- Average volume
- 2,535,600
- Market cap
- 325M+
- 52-week range
- $1.69 – $5.17
- 50-day average
- $3.05
- 200-day average
- $3.26
Price action over the past year
In 252 trading sessions since November 20, 2025, CCCC closed higher on 115 days (46%).
Its best day was May 29, 2026 (+19.40%) and its worst was March 10, 2026 (-13.09%).
The stock moved 10% or more in a single session 12 times.
Recent signals
CCCC news
-
Nov 18, 2026:
Is C4 Therapeutics (CCCC) Outperforming Other Medical Stocks This Year?
-
Nov 5, 2026:
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Lags Revenue Estimates
-
Nov 5, 2026:
C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
-
Nov 4, 2026:
Acadia Pharmaceuticals (ACAD) Tops Q3 Earnings and Revenue Estimates
-
Nov 3, 2026:
C4 Therapeutics to Participate in Upcoming November Investor Conferences
-
Nov 2, 2026:
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Oct 29, 2026:
C4 Therapeutics, Inc. (CCCC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Oct 29, 2026:
C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders
About C4 Therapeutics, Inc.
C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
Similar stocks
Find more stocks like CCCC with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.